Evenity?▼ Europe In Europe, EVENITY? (romosozumab) is indicated in the treatment of severe osteoporosis in postmenopausal women at high risk of fracture. ▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Prescribing information Europe
